Posted inLondon Exchange London Stock Exchange
Syncona to sell Clade Therapeutics to Century Therapeutics for $45 million
LONDON: Syncona Ltd has signed an agreement for the sale of its portfolio company Clade Therapeutics to Century Therapeutics for $45 million. Century is a biotechnology company developing induced pluripotent…